WILTON, Conn., Jan. 26, 2016 -- Wilton based Blue Buffalo Pet Products Inc. (Nasdaq:BUFF) will release its results for fourth quarter and full year 2015 after the market closes on Tuesday, March 8, 2016.
The company has scheduled a conference call on Tuesday, March 8, 2016 at 5:00pm Eastern Time. During the conference call Kurt Schmidt, Chief Executive Officer, William (Billy) Bishop Jr., President and Chief Operating Officer, and Mike Nathenson, Chief Financial Officer, will discuss the fourth quarter and full year 2015 results and answer questions from the investment community.
You may dial in to the earnings call at the following numbers:
Participant Toll-Free Dial-In Number: 855-539-0894
Participant International Toll-Free Dial-In Number: 412-455-6023
Conference ID #: 28582096
Within two hours after the conference call is completed a digital recording of the conference call will be available for replay. The date range that the conference call replay will be available is listed below. To access the recording please use the dial-in number listed below and the conference ID shown above.
Dial In: 855-859-2056 or 404-537-3406
Earnings Call Replay Available Dates: 03/08/2016 20:00 Eastern Time to 03/22/2016 23:59 Eastern Time
About Blue Buffalo
Blue Buffalo, based in Wilton, CT, is the nation's leading natural pet food company, and provides natural foods and treats for dogs and cats under its BLUE Life Protection Formula, BLUE Wilderness, BLUE Basics, BLUE Freedom and BLUE Natural Veterinary Diet lines. Paying tribute to its founding mission, the Company, through the Blue Buffalo Foundation for Cancer Research, is also a leading sponsor of pet cancer awareness and of critical studies of pet cancer, health, treatment and nutrition at top veterinary medical schools across the United States. For more information about Blue Buffalo, visit the Company’s website at www.BlueBuffalo.com.
Contacts: Investors & Financial Analysts Michael Nathenson EVP & CFO 203-665-3400 [email protected] Media Phil Cheevers VP, Communications 203-665-3234 [email protected]


Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 



